Ozempic-like drugs may reduce cravings for addictive substances by targeting the brain's lateral septum

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists are increasingly tracing this effect to the lateral septum, a brain region that helps connect memories and surroundings with rewarding experiences. Packed with GLP-1 receptors, it may act as a crucial control point between thinking about a reward and feeling compelled to pursue it. The discovery could open new approaches to treating addiction as well as obesity. The lateral septum's involvement in addiction is supported by studies using animal models, which show that manipulating this region can alter the desire for substances. This suggests that targeting the lateral septum may be a viable strategy for treating addiction. However, it is essential to note that this research is still in its early stages and more studies are needed to confirm these findings in humans. The current understanding of the lateral septum's role in addiction is limited, and further investigation is required to fully elucidate its mechanisms. While this discovery may hold promise for treating addiction, it is not a replacement for established treatments and should be used under the guidance of a qualified healthcare professional.